Targeting Ebola Virus Replication through Pharmaceutical Intervention
Hansen, F. and Feldmann, H.
(2021).
Targeting Ebola Virus Replication through Pharmaceutical Intervention.
(Abstract only.) Expert Opinion on Investigational Drugs. 30(3):201-226.
This article discusses pharmaceutical interventions which can be used to treat Ebola virus disease. In particular, it examines the FDA-approved monoclonal antibody Inmazeb and the possibility of combining this with other pharmaceuticals which disrupt viral replication.
Rate:
Favorite:
Login to rate, favorite, and comments
on the article
Comments
0
Toggle Open/Close
You must Login to add a comment
- This item doesn't have any comments